Insider Transactions in Q3 2024 at Nuvalent, Inc. (NUVL)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 15
2024
|
Emily Conley |
SELL
Open market or private sale
|
Direct |
5,000
-22.38%
|
$400,000
$80.76 P/Share
|
Jul 15
2024
|
Emily Conley |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+39.98%
|
$65,000
$13.79 P/Share
|
Jul 12
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,000
-15.27%
|
$480,000
$80.16 P/Share
|
Jul 12
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+13.25%
|
$162,000
$27.85 P/Share
|
Jul 09
2024
|
Henry E. Pelish Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,100
+14.61%
|
-
|
Jul 08
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.82%
|
$219,000
$73.07 P/Share
|
Jul 08
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.63%
|
$18,000
$6.89 P/Share
|
Jul 01
2024
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.62%
|
$375,000
$75.83 P/Share
|
Jul 01
2024
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.55%
|
$90,000
$18.93 P/Share
|